-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.0068.78% Upside
ImmunityBio, Inc. Frequently Asked Questions
-
What analysts cover ImmunityBio, Inc.?
ImmunityBio, Inc. has been rated by research analysts at Jefferies in the past 90 days.